Nephros (NEPH) Invested Capital (2010 - 2026)

Nephros' Invested Capital history runs 17 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• In Q1 2026, Invested Capital rose 15.18% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (up 15.18% YoY), while the FY2025 annual figure was $10.2 million, up 18.84% from the prior year.
• Invested Capital was $10.7 million for Q1 2026 at Nephros, up from $10.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $13.7 million in Q1 2022 to a low of $7.9 million in Q2 2024.
• Historically, Invested Capital has averaged $9.5 million across 5 years, with a median of $9.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Invested Capital plunged 40.31% in 2022, then increased 22.41% in 2025.
• A 5-year view of Invested Capital shows it stood at $9.0 million in 2022, then decreased by 6.64% to $8.4 million in 2023, then gained by 2.72% to $8.6 million in 2024, then advanced by 18.84% to $10.2 million in 2025, then rose by 4.89% to $10.7 million in 2026.
• The last three Invested Capital figures came in at $10.7 million (Q1 2026), $10.2 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.